Department of Twin Research and Genetic Epidemiology, London, UK.
BMC Cardiovasc Disord. 2013 Apr 3;13:25. doi: 10.1186/1471-2261-13-25.
Excess accumulation of visceral fat is a prominent risk factor for cardiovascular and metabolic morbidity. While computed tomography (CT) is the gold standard to measure visceral adiposity, this is often not possible for large studies - thus valid, but less expensive and intrusive proxy measures of visceral fat are required such as dual-energy X-ray absorptiometry (DXA). Study aims were to a) identify a valid DXA-based measure of visceral adipose tissue (VAT), b) estimate VAT heritability and c) assess visceral fat association with morbidity in relation to body fat distribution.
A validation sample of 54 females measured for detailed body fat composition - assessed using CT, DXA and anthropometry - was used to evaluate previously published predictive models of CT-measured visceral fat. Based upon a validated model, we realised an out-of-sample estimate of abdominal VAT area for a study sample of 3457 female volunteer twins and estimated VAT area heritability using a classical twin study design. Regression and residuals analyses were used to assess the relationship between adiposity and morbidity.
Published models applied to the validation sample explained >80% of the variance in CT-measured visceral fat. While CT visceral fat was best estimated using a linear regression for waist circumference, CT body cavity area and total abdominal fat (R2 = 0.91), anthropometric measures alone predicted VAT almost equally well (CT body cavity area and waist circumference, R2 = 0.86). Narrow sense VAT area heritability for the study sample was estimated to be 58% (95% CI: 51-66%) with a shared familial component of 24% (17-30%). VAT area is strongly associated with type 2 diabetes (T2D), hypertension (HT), subclinical atherosclerosis and liver function tests. In particular, VAT area is associated with T2D, HT and liver function (alanine transaminase) independent of DXA total abdominal fat and body mass index (BMI).
DXA and anthropometric measures can be utilised to derive estimates of visceral fat as a reliable alternative to CT. Visceral fat is heritable and appears to mediate the association between body adiposity and morbidity. This observation is consistent with hypotheses that suggest excess visceral adiposity is causally related to cardiovascular and metabolic disease.
内脏脂肪过多是心血管和代谢疾病发病的一个显著危险因素。 虽然计算机断层扫描(CT)是测量内脏脂肪的金标准,但对于大型研究来说,这往往是不可能的 - 因此需要有效的、但代价较低且侵入性较小的内脏脂肪替代指标,如双能 X 射线吸收法(DXA)。本研究旨在:a)确定一种基于 DXA 的有效的内脏脂肪组织(VAT)测量方法,b)估计 VAT 的遗传度,c)评估与体脂分布相关的内脏脂肪与发病率的关系。
使用经过 CT、DXA 和人体测量学评估的详细身体脂肪成分的验证样本(54 名女性)来评估先前发表的 CT 测量内脏脂肪的预测模型。基于验证模型,我们为 3457 名女性志愿者双胞胎的研究样本实现了腹部 VAT 面积的样本外估计,并使用经典的双胞胎研究设计来估计 VAT 面积的遗传度。回归和残差分析用于评估肥胖与发病率之间的关系。
应用于验证样本的已发表模型解释了 CT 测量的内脏脂肪的 >80%的方差。虽然 CT 内脏脂肪最好通过腰围、CT 体腔面积和总腹部脂肪的线性回归来估计(R2 = 0.91),但单独的人体测量指标也能很好地预测 VAT(CT 体腔面积和腰围,R2 = 0.86)。研究样本的 VAT 面积狭义遗传度估计为 58%(95%CI:51-66%),具有 24%(17-30%)的共享家族成分。VAT 面积与 2 型糖尿病(T2D)、高血压(HT)、亚临床动脉粥样硬化和肝功能检查密切相关。特别是,VAT 面积与 T2D、HT 和肝功能(丙氨酸转氨酶)相关,与 DXA 总腹部脂肪和体重指数(BMI)无关。
DXA 和人体测量指标可用于得出内脏脂肪的估计值,作为 CT 的可靠替代方法。内脏脂肪是遗传的,似乎介导了身体肥胖与发病率之间的关系。这一观察结果与假设一致,即过多的内脏脂肪与心血管和代谢疾病有因果关系。